Trajectories of antidepressant use after tamoxifen initiation among young and middle-aged women with breast cancer.

Autor: Onasanya O; Department of Practice, Sciences, and Health Outcomes Research, School of Pharmacy, University of Maryland Baltimore, 220 N Arch Street- 12th Floor, Baltimore, MD, 21201, USA.; Carelon Research (Formerly HealthCore, Inc.), Safety & Epidemiology, Wilmington, DE, USA., Rosenblatt P; Division of Hematology and Oncology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., dosReis S; Department of Practice, Sciences, and Health Outcomes Research, School of Pharmacy, University of Maryland Baltimore, 220 N Arch Street- 12th Floor, Baltimore, MD, 21201, USA., Onukwugha E; Department of Practice, Sciences, and Health Outcomes Research, School of Pharmacy, University of Maryland Baltimore, 220 N Arch Street- 12th Floor, Baltimore, MD, 21201, USA., Zafari Z; Department of Practice, Sciences, and Health Outcomes Research, School of Pharmacy, University of Maryland Baltimore, 220 N Arch Street- 12th Floor, Baltimore, MD, 21201, USA.; University of Maryland Institute for Health Computing, North Bethesda, MD, USA., Camelo Castillo W; Department of Practice, Sciences, and Health Outcomes Research, School of Pharmacy, University of Maryland Baltimore, 220 N Arch Street- 12th Floor, Baltimore, MD, 21201, USA. wcastillo@rx.umaryland.edu.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Nov 15. Date of Electronic Publication: 2024 Nov 15.

Geographic Trends in Pediatric Psychotropic Medication Dispensing Before and After the Start of the COVID-19 Pandemic.

Autor: Bushnell G; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey (Bushnell, Gerhard, Horton); Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey (Bushnell, Gerhard, Horton); Safety Surveillance Research, Pfizer, New York City (Sun); Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore (dosReis, Camelo Castillo, Lee); Department of Pediatrics, University of Colorado School of Medicine, Aurora (Czaja); Department of Medical and Clinical Pharmacology, Center of Pharmacovigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France (Durrieu); Center of Clinical Investigations, Inserm CIC1426, Robert Debré Hospital, Paris Cité University-National Institute of Health and Medical Research, Paris (Kaguelidou); School of Nursing-Camden, Rutgers, the State University of New Jersey, Camden (Pudasainee-Kapri); Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina (Raman); GlaxoSmithKline, Rockville, Maryland (Spence)., Sun JW; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey (Bushnell, Gerhard, Horton); Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey (Bushnell, Gerhard, Horton); Safety Surveillance Research, Pfizer, New York City (Sun); Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore (dosReis, Camelo Castillo, Lee); Department of Pediatrics, University of Colorado School of Medicine, Aurora (Czaja); Department of Medical and Clinical Pharmacology, Center of Pharmacovigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France (Durrieu); Center of Clinical Investigations, Inserm CIC1426, Robert Debré Hospital, Paris Cité University-National Institute of Health and Medical Research, Paris (Kaguelidou); School of Nursing-Camden, Rutgers, the State University of New Jersey, Camden (Pudasainee-Kapri); Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina (Raman); GlaxoSmithKline, Rockville, Maryland (Spence)., dosReis S; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey (Bushnell, Gerhard, Horton); Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey (Bushnell, Gerhard, Horton); Safety Surveillance Research, Pfizer, New York City (Sun); Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore (dosReis, Camelo Castillo, Lee); Department of Pediatrics, University of Colorado School of Medicine, Aurora (Czaja); Department of Medical and Clinical Pharmacology, Center of Pharmacovigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France (Durrieu); Center of Clinical Investigations, Inserm CIC1426, Robert Debré Hospital, Paris Cité University-National Institute of Health and Medical Research, Paris (Kaguelidou); School of Nursing-Camden, Rutgers, the State University of New Jersey, Camden (Pudasainee-Kapri); Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina (Raman); GlaxoSmithKline, Rockville, Maryland (Spence)., Camelo Castillo W; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey (Bushnell, Gerhard, Horton); Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey (Bushnell, Gerhard, Horton); Safety Surveillance Research, Pfizer, New York City (Sun); Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore (dosReis, Camelo Castillo, Lee); Department of Pediatrics, University of Colorado School of Medicine, Aurora (Czaja); Department of Medical and Clinical Pharmacology, Center of Pharmacovigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France (Durrieu); Center of Clinical Investigations, Inserm CIC1426, Robert Debré Hospital, Paris Cité University-National Institute of Health and Medical Research, Paris (Kaguelidou); School of Nursing-Camden, Rutgers, the State University of New Jersey, Camden (Pudasainee-Kapri); Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina (Raman); GlaxoSmithKline, Rockville, Maryland (Spence)., Czaja AS; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey (Bushnell, Gerhard, Horton); Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey (Bushnell, Gerhard, Horton); Safety Surveillance Research, Pfizer, New York City (Sun); Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore (dosReis, Camelo Castillo, Lee); Department of Pediatrics, University of Colorado School of Medicine, Aurora (Czaja); Department of Medical and Clinical Pharmacology, Center of Pharmacovigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France (Durrieu); Center of Clinical Investigations, Inserm CIC1426, Robert Debré Hospital, Paris Cité University-National Institute of Health and Medical Research, Paris (Kaguelidou); School of Nursing-Camden, Rutgers, the State University of New Jersey, Camden (Pudasainee-Kapri); Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina (Raman); GlaxoSmithKline, Rockville, Maryland (Spence)., Durrieu G; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey (Bushnell, Gerhard, Horton); Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey (Bushnell, Gerhard, Horton); Safety Surveillance Research, Pfizer, New York City (Sun); Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore (dosReis, Camelo Castillo, Lee); Department of Pediatrics, University of Colorado School of Medicine, Aurora (Czaja); Department of Medical and Clinical Pharmacology, Center of Pharmacovigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France (Durrieu); Center of Clinical Investigations, Inserm CIC1426, Robert Debré Hospital, Paris Cité University-National Institute of Health and Medical Research, Paris (Kaguelidou); School of Nursing-Camden, Rutgers, the State University of New Jersey, Camden (Pudasainee-Kapri); Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina (Raman); GlaxoSmithKline, Rockville, Maryland (Spence)., Gerhard T; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey (Bushnell, Gerhard, Horton); Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey (Bushnell, Gerhard, Horton); Safety Surveillance Research, Pfizer, New York City (Sun); Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore (dosReis, Camelo Castillo, Lee); Department of Pediatrics, University of Colorado School of Medicine, Aurora (Czaja); Department of Medical and Clinical Pharmacology, Center of Pharmacovigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France (Durrieu); Center of Clinical Investigations, Inserm CIC1426, Robert Debré Hospital, Paris Cité University-National Institute of Health and Medical Research, Paris (Kaguelidou); School of Nursing-Camden, Rutgers, the State University of New Jersey, Camden (Pudasainee-Kapri); Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina (Raman); GlaxoSmithKline, Rockville, Maryland (Spence)., Lee H; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey (Bushnell, Gerhard, Horton); Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey (Bushnell, Gerhard, Horton); Safety Surveillance Research, Pfizer, New York City (Sun); Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore (dosReis, Camelo Castillo, Lee); Department of Pediatrics, University of Colorado School of Medicine, Aurora (Czaja); Department of Medical and Clinical Pharmacology, Center of Pharmacovigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France (Durrieu); Center of Clinical Investigations, Inserm CIC1426, Robert Debré Hospital, Paris Cité University-National Institute of Health and Medical Research, Paris (Kaguelidou); School of Nursing-Camden, Rutgers, the State University of New Jersey, Camden (Pudasainee-Kapri); Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina (Raman); GlaxoSmithKline, Rockville, Maryland (Spence)., Kaguelidou F; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey (Bushnell, Gerhard, Horton); Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey (Bushnell, Gerhard, Horton); Safety Surveillance Research, Pfizer, New York City (Sun); Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore (dosReis, Camelo Castillo, Lee); Department of Pediatrics, University of Colorado School of Medicine, Aurora (Czaja); Department of Medical and Clinical Pharmacology, Center of Pharmacovigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France (Durrieu); Center of Clinical Investigations, Inserm CIC1426, Robert Debré Hospital, Paris Cité University-National Institute of Health and Medical Research, Paris (Kaguelidou); School of Nursing-Camden, Rutgers, the State University of New Jersey, Camden (Pudasainee-Kapri); Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina (Raman); GlaxoSmithKline, Rockville, Maryland (Spence)., Pudasainee-Kapri S; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey (Bushnell, Gerhard, Horton); Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey (Bushnell, Gerhard, Horton); Safety Surveillance Research, Pfizer, New York City (Sun); Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore (dosReis, Camelo Castillo, Lee); Department of Pediatrics, University of Colorado School of Medicine, Aurora (Czaja); Department of Medical and Clinical Pharmacology, Center of Pharmacovigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France (Durrieu); Center of Clinical Investigations, Inserm CIC1426, Robert Debré Hospital, Paris Cité University-National Institute of Health and Medical Research, Paris (Kaguelidou); School of Nursing-Camden, Rutgers, the State University of New Jersey, Camden (Pudasainee-Kapri); Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina (Raman); GlaxoSmithKline, Rockville, Maryland (Spence)., Raman SR; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey (Bushnell, Gerhard, Horton); Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey (Bushnell, Gerhard, Horton); Safety Surveillance Research, Pfizer, New York City (Sun); Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore (dosReis, Camelo Castillo, Lee); Department of Pediatrics, University of Colorado School of Medicine, Aurora (Czaja); Department of Medical and Clinical Pharmacology, Center of Pharmacovigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France (Durrieu); Center of Clinical Investigations, Inserm CIC1426, Robert Debré Hospital, Paris Cité University-National Institute of Health and Medical Research, Paris (Kaguelidou); School of Nursing-Camden, Rutgers, the State University of New Jersey, Camden (Pudasainee-Kapri); Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina (Raman); GlaxoSmithKline, Rockville, Maryland (Spence)., Spence O; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey (Bushnell, Gerhard, Horton); Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey (Bushnell, Gerhard, Horton); Safety Surveillance Research, Pfizer, New York City (Sun); Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore (dosReis, Camelo Castillo, Lee); Department of Pediatrics, University of Colorado School of Medicine, Aurora (Czaja); Department of Medical and Clinical Pharmacology, Center of Pharmacovigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France (Durrieu); Center of Clinical Investigations, Inserm CIC1426, Robert Debré Hospital, Paris Cité University-National Institute of Health and Medical Research, Paris (Kaguelidou); School of Nursing-Camden, Rutgers, the State University of New Jersey, Camden (Pudasainee-Kapri); Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina (Raman); GlaxoSmithKline, Rockville, Maryland (Spence)., Horton DB; Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey (Bushnell, Gerhard, Horton); Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey (Bushnell, Gerhard, Horton); Safety Surveillance Research, Pfizer, New York City (Sun); Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore (dosReis, Camelo Castillo, Lee); Department of Pediatrics, University of Colorado School of Medicine, Aurora (Czaja); Department of Medical and Clinical Pharmacology, Center of Pharmacovigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France (Durrieu); Center of Clinical Investigations, Inserm CIC1426, Robert Debré Hospital, Paris Cité University-National Institute of Health and Medical Research, Paris (Kaguelidou); School of Nursing-Camden, Rutgers, the State University of New Jersey, Camden (Pudasainee-Kapri); Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina (Raman); GlaxoSmithKline, Rockville, Maryland (Spence).

Publikováno v: Psychiatric services (Washington, D.C.) [Psychiatr Serv] 2023 Aug 01; Vol. 74 (8), pp. 880-884. Date of Electronic Publication: 2023 Feb 08.

FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology.

Autor: Russell ES; Merck & Co., Inc., Rahway, NJ, USA., Aubrun E; Novartis Pharma AG, Basel, Switzerland., Moga DC; University of Kentucky, College of Pharmacy, Lexington, KY, USA., Guedes S; Ferring Pharmaceuticals A/S, Copenhagen, Denmark., Camelo Castillo W; University of Maryland School of Pharmacy, Baltimore, MD, USA., Hardy JR; Biohaven Pharmaceuticals Holding Company Ltd., New Haven, CT, USA., Cole JA; Alexion - AstraZeneca Rare Disease, Boston, MA, USA., Jagun O; Pfizer Inc., New York, NY, USA.

Publikováno v: Journal of clinical and translational science [J Clin Transl Sci] 2023 May 02; Vol. 7 (1), pp. e101. Date of Electronic Publication: 2023 May 02 (Print Publication: 2023).

Adverse outcomes associated with concurrent gabapentin, opioid, and benzodiazepine utilization: A nested case-control study.

Autor: Olopoenia A; Department of Pharmaceutical Health Services Research, University of Maryland Baltimore, Baltimore, MD, USA., Camelo-Castillo W; Department of Pharmaceutical Health Services Research, University of Maryland Baltimore, Baltimore, MD, USA., Qato DM; Department of Pharmaceutical Health Services Research, University of Maryland Baltimore, Baltimore, MD, USA.; School of Medicine, University of Maryland Baltimore, Baltimore, MD, USA., Adekoya A; Johns Hopkins Medicine, Department of Anesthesiology & Critical Care Medicine, Division of Chronic Pain Medicine, Baltimore, MD, USA., Palumbo F; Department of Pharmaceutical Health Services Research, University of Maryland Baltimore, Baltimore, MD, USA., Sera L; Department of Pharmacy Practice and Science, University of Maryland Baltimore, Baltimore, MD, USA., Simoni-Wastila L; Department of Pharmaceutical Health Services Research, University of Maryland Baltimore, Baltimore, MD, USA.; Peter Lamy Center on Drug Therapy and Aging, University of Maryland Baltimore, Baltimore, MD, USA.

Publikováno v: Lancet regional health. Americas [Lancet Reg Health Am] 2022 Jun 23; Vol. 13, pp. 100302. Date of Electronic Publication: 2022 Jun 23 (Print Publication: 2022).

Patterns of opioid and benzodiazepine use with gabapentin among disabled Medicare beneficiaries - A retrospective cohort study.

Autor: Olopoenia A; University of Maryland, Baltimore, Department of Pharmaceutical Health Services Research, 220N. Arch St., Baltimore, MD 21201, United States. Electronic address: aolopoenia@umaryland.edu., Camelo-Castillo W; University of Maryland, Baltimore, Department of Pharmaceutical Health Services Research, 220N. Arch St., Baltimore, MD 21201, United States. Electronic address: wcastillo@rx.umaryland.edu., Qato DM; University of Maryland, Baltimore, Department of Pharmaceutical Health Services Research, 220N. Arch St., Baltimore, MD 21201, United States; University of Maryland, Baltimore, School of Medicine, 655W. Baltimore St, Baltimore, MD 21201, United States. Electronic address: dqato@rx.umaryland.edu., Adekoya A; Johns Hopkins Medicine, Department of Anesthesiology & Critical Care Medicine, Division of Chronic Pain Medicine, United States. Electronic address: padekoy3@jhmi.edu., Palumbo F; University of Maryland, Baltimore, Department of Pharmaceutical Health Services Research, 220N. Arch St., Baltimore, MD 21201, United States. Electronic address: fpalumbo@rx.umaryland.edu., Sera L; University of Maryland, Baltimore, Department of Pharmacy Practice and Science, United States. Electronic address: lsera@rx.umaryland.edu., Simoni-Wastila L; University of Maryland, Baltimore, Department of Pharmaceutical Health Services Research, 220N. Arch St., Baltimore, MD 21201, United States; Peter Lamy Center on Drug Therapy and Aging, University of Maryland Baltimore, Baltimore, United States. Electronic address: lsimoniw@rx.umaryland.edu.

Publikováno v: Drug and alcohol dependence [Drug Alcohol Depend] 2022 Jan 01; Vol. 230, pp. 109180. Date of Electronic Publication: 2021 Nov 17.